BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Engineering Events - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Engineering Events
X-ORIGINAL-URL:https://seasevents.nmsdev7.com
X-WR-CALDESC:Events for Penn Engineering Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230125T153000
DTEND;TZID=America/New_York:20230125T163000
DTSTAMP:20260405T014204
CREATED:20230119T152806Z
LAST-MODIFIED:20230119T152806Z
UID:8215-1674660600-1674664200@seasevents.nmsdev7.com
SUMMARY:CBE/BE Seminar: "Targeting Sugars for Immunotherapy in Cancer and Beyond" (Jessica Stark\, Stanford)
DESCRIPTION:Co-hosted by the Departments of Chemical and Biomolecular Engineering & Bioengineering. \nNew paradigms to harness the immune system are urgently needed to address unmet needs in human health. I am working to understand and engineer glycoimmunology – the roles of sugars\, or glycans\, in the immune system – to bridge this gap. During my PhD\, I developed a platform called iVAX for rapid and portable production of conjugate vaccines\, a class of FDA-approved vaccines that use glycans to elicit antibacterial immunity. I showed that iVAXderived conjugate vaccines protected mice against lethal pathogen challenge. My iVAX approach has the potential to accelerate development and distribution of vaccines to address emerging drug-resistant bacteria. As a postdoctoral fellow\, I designed antibody-lectin (AbLec) chimeras to target glycans that act as immune checkpoints in cancer. I showed that AbLecs potentiated tumor killing by binding and blocking tumor-associated glycans that otherwise inhibit anti-cancer immune responses. AbLecs represent a new modality of cancer immunotherapy that promises to increase the fraction of patients who benefit from treatment. My independent group will work to realize the full potential of glycoimmunology for human health\, by developing new immunotherapy modalities and uncovering new drug targets.While we will initially focus on fundamental questions and therapeutic applications in cancer\, in the long term we will apply our synergistic platform technologies to additional therapeutic contexts\, including autoimmunity\, infection\, and neurodegeneration.
URL:https://seasevents.nmsdev7.com/event/cbe-be-seminar-targeting-sugars-for-immunotherapy-in-cancer-and-beyond-jessica-stark-stanford/
LOCATION:Wu and Chen Auditorium (Room 101)\, Levine Hall\, 3330 Walnut Street\, Philadelphia\, PA\, 19104\, United States
CATEGORIES:Seminar,Postdoctoral
ORGANIZER;CN="Chemical and Biomolecular Engineering":MAILTO:cbemail@seas.upenn.edu
END:VEVENT
END:VCALENDAR